[Red yeast-rice-induced muscular injuries: Analysis of French pharmacovigilance database and literature review] - PubMed (original) (raw)

. 2023 Sep-Oct;78(5S):S31-S40.

doi: 10.2515/therapie/2015053. Epub 2016 Oct 27.

[Article in French]

Affiliations

[Red yeast-rice-induced muscular injuries: Analysis of French pharmacovigilance database and literature review]

[Article in French]

Christelle Philibert et al. Therapie. 2023 Sep-Oct.

Abstract

Red yeast rice (RYR) is a dietary supplement containing monacolins obtained by fermentation of Monascus purpureus strains. Because of its structural homology with lovastatin, monacolin K inhibits HMG-CoA reductase and shows hypocholesterolemic properties comparable to synthetic statins. We studied all cases of myopathy involving RYR reported in the French national pharmacovigilance database (6 cases) and in scientific literature (9 cases). Among these cases, 9 showed elevated creatine kinase, 3 rhabdomyolysis and 2 myalgia. Recent studies seem to show good efficacy of the RYR, however, our work reports the existence of related muscular disorders. In addition, dietary supplements currently available on the market may show considerable variability of formulation and/or the presence of contaminants. When clinicobiological disorders occur, physicians should consider the eventual use of an herbal treatment.

Keywords: Atteintes musculaires; Levure de riz rouge; Muscular injuries; Phytotherapy; Phytothérapie; Red yeast rice; Statin; Statine.

Copyright © 2014 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

PubMed Disclaimer

Similar articles

Cited by

Publication types

LinkOut - more resources